Skip to content

Total costs & expenses at other companies

Repligen logo
RepligenRGEN
$178.32M+9.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$47.63M+24.4%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$156.58M+16.5%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Agilent Technologies logo
Agilent TechnologiesA
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s total costs & expenses?
Maravai LifeSciences Holdings, Inc. (MRVI) reported total costs & expenses of $35.86M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s total costs & expenses changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s total costs & expenses decreased by 37.0% year-over-year, from $56.89M to $35.86M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s total costs & expenses?
Over 3 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s total costs & expenses has grown at a 5.7% compound annual growth rate (CAGR), from $244.6M to $288.89M.
What does total costs & expenses mean?
This metric aggregates all operating and non-operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and administrative overhead. It provides a comprehensive view of the company's total expenditure structure and operational efficiency. Monitoring this figure helps evaluate the company's ability to manage its cost base relative to its revenue growth.